Muvalaplin (LY3473329) is a first-in-class, orally active lipoprotein (a) (Lp(a)) inhibitor that inhibits Lp(a) formation by blocking apolipoprotein apo(a)-apo B100 interactions and avoids interaction with the cognate protein fibrinogen. In addition, Muvalaplin is used in the study of cardiovascular and metabolism-related diseases.
Molekulargewicht:
710.90
Reinheit:
>99.0%
CAS Nummer:
[2565656-70-2]
Formel:
C42H54N4O6
Target-Kategorie:
Lipoprotein (a)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten